Abcellera Biologics Inc. number of employees

Abcellera Biologics Inc. reported 562 employees at December 31, 2025 in its latest annual report. Revenue per employee was $133,680.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	562	—	$133,680	10-K, filed February 24, 2026

What the annual reports say

As of December 31, 2025, we had 562 full-time employees in Canada, Australia, and the United States, representing over 42 national 2025 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: ABCL vs CYTK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Abcellera Biologics Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Abcellera Biologics Inc.